<DOC>
	<DOC>NCT02225353</DOC>
	<brief_summary>Assess the efficacy of 2 Cervical Pessaries containing 6.3 g and 7.7 g micronized progesterone for the prevention of preterm delivery, established through spontaneous birth before gestation weeks 32 (31 6/7) and 34 (33 6/7), when the pessary is inserted during weeks 16th and 24th and removed at 36 6/7 weeks in pregnant women at high risk of premature birth.</brief_summary>
	<brief_title>Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Women with a singleton intrauterine pregnancy, with 1025 mm cervical length between gestation weeks 16 and 24, with no prior risk factors. Women with a singleton intrauterine pregnancy with 10 mm or more cervical length between 16 and 24 weeks of gestation, with prior risk factors: Prior history of preterm delivery before gestation week 35 Prior history of premature rupture of membranes before gestation week 35 Pregnancies with: Major fetal abnormalities, such as lethal malformations or defects requiring pre or postnatal surgery; and fetal death before randomization. Prior history of premature rupture of membranes or prophylactic cervical cerclage before study entry. Cervical and/or vaginal injuries prior to pessary insertion (e.g., cervical erosion secondary to trauma, infection, or cancer; vesicovaginal or rectovaginal fistulas). Unconscious, severely ill or mentally disabled women, or women 16 years of age or younger</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Cervical Pessaries</keyword>
	<keyword>Progesterone</keyword>
</DOC>